435 (Metformin 850 mg)
Pill imprint 435 has been identified as Metformin hydrochloride 850 mg.
Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 435 (Metformin 850 mg)
- 850 mg
- 12.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Caraco Pharmaceutical Laboratories
- National Drug Code (NDC):
- Inactive Ingredients:
|NDC Code||Manufacturer / Repackager|
|63739-0300||McKesson Packaging Services|
|67544-0107||Prepak Systems Inc (repackager)|
|55887-0614||Diversified Healthcare Services Inc (repackager)|
|21695-0472||Rebel Distributors Corp (repackager)|
|55289-0934||PDRX Pharmaceuticals Inc (repackager)|
Note: Inactive ingredients may vary.